Abstract
Introduction: Recent work on dysplastic lesions has shown that promoter methylation may be a predictive biomarker for malignant transformation to squamous cell carcinoma. Saliva shows promise as a tumour surrogate, but has not been investigated in the context of dysplasia. We investigated two methods of saliva collection for DNA yield and quality, as determined by epigenetic marker analysis, and the logistics of collection and storage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
